Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "Clinical Nutrition Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Clinical Nutrition Products is estimated at US$40.2 Billion in 2023 and is projected to reach US$53.1 Billion by 2030, growing at a CAGR of 4.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
The growth in the clinical nutrition products market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with a rising geriatric population susceptible to nutritional deficiencies, significantly drives market demand. Secondly, advancements in medical research and technology are leading to the development of more effective, specialized, and condition-specific nutritional products, enhancing their adoption in clinical settings. Thirdly, growing awareness about the critical role of nutrition in disease management, recovery, and overall health maintenance is propelling the adoption of clinical nutrition products among healthcare providers and patients alike.
Additionally, the expansion of healthcare infrastructure, especially in emerging economies, is improving access to clinical nutrition services, thus broadening the market. The trend towards home healthcare and the increasing preference for minimally invasive treatment options also contribute to market growth, as these solutions offer convenience and improved quality of life for patients.
Furthermore, supportive government initiatives and policies aimed at enhancing nutritional standards and backing clinical nutrition programs are bolstering market development. Collectively, these factors are expected to drive growth in the clinical nutrition products market, ensuring that more patients receive the nutritional support they need for optimal health outcomes.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Oral Nutrition segment, which is expected to reach US$28.7 Billion by 2030 with a CAGR of a 4.5%. The Enteral Nutrition segment is also set to grow at 3.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $10.9 Billion in 2023, and China, forecasted to grow at an impressive 6.9% CAGR to reach $11.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Nutrition, B. Braun Melsungen AG, Baxter International Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 269 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $40.2 Billion |
| Forecasted Market Value (USD) by 2030 | $53.1 Billion |
| Compound Annual Growth Rate | 4.1% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Clinical Nutrition Products - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Increasing Prevalence of Chronic Diseases Expands Addressable Market Opportunity for Clinical Nutrition
- Rising Geriatric Population Throws the Spotlight on Nutritional Deficiencies and Market Demand
- Advancements in Nutrient Formulations Propel Growth in Specialized Clinical Nutrition Products
- Development of Personalized Nutrition Solutions Strengthens Business Case for Tailored Products
- Growing Awareness of the Role of Nutrition in Disease Management Drives Adoption of Clinical Nutrition Products
- Integration of Digital Health Technologies Generates Opportunities for Enhanced Nutritional Monitoring
- Home Healthcare and Minimally Invasive Treatment Options Propel Demand for Clinical Nutrition
- Increased Focus on Post-Operative and Critical Care Nutrition Impacts Market Demand
- Innovations in Enteral and Parenteral Nutrition Delivery Systems Generate Demand for Advanced Products
- Rising Healthcare Expenditure and Insurance Coverage Expand Addressable Market Opportunity
- Enhanced Focus on Pediatric and Maternal Nutrition Strengthens Business Case for Specialized Solutions
- Adoption of Nutritional Therapy in Cancer Care Throws the Spotlight on Market Growth
- Increasing Utilization of Clinical Nutrition in Long-Term Care Facilities
- Expansion of Nutrition Programs in Hospital and Clinical Settings Propels Market Adoption
- Technological Innovations in Nutrient Bioavailability and Absorption Propel Product Development
- Focus on Reducing Malnutrition in Developing Regions Generates Opportunities for Market Expansion
FOCUS ON SELECT PLAYERS(Total 33 Featured)
- Abbott Nutrition
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Kabi AG
- Groupe Danone
- ICU Medical Inc.
- Mead Johnson & Company LLC
- Meiji Co. Ltd.
- Nestle Health Science S.A
- Nutricia North America
- Otsuka Pharmaceutical Factory Inc.
For more information about this report visit https://www.researchandmarkets.com/r/nfwksw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
